Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
63.6M
-
Number of holders
-
133
-
Total shares
-
34.7M
-
Shares change
-
+10.3M
-
Total reported value, excl. options
-
$1.38B
-
Value change
-
+$410M
-
Put/Call ratio
-
0.61
-
Number of buys
-
93
-
Number of sells
-
-36
-
Price
-
$39.99
Significant Holders of Blueprint Medicines Corp - Common Stock (BPMC) as of Q1 2017
137 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock as of Q1 2017.
Blueprint Medicines Corp - Common Stock (BPMC) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.7M shares
of 63.6M outstanding shares and own 54.51% of the company stock.
Largest 10 shareholders include FMR LLC (4.78M shares), WELLINGTON MANAGEMENT GROUP LLP (3.82M shares), BVF INC/IL (2.1M shares), BlackRock Inc. (2.05M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.01M shares), LORD, ABBETT & CO. LLC (1.72M shares), DEERFIELD MANAGEMENT CO (1.37M shares), VANGUARD GROUP INC (1.22M shares), Partner Fund Management, L.P. (1.05M shares), and ALLIANCEBERNSTEIN L.P. (973K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.